Cardium Therapeutics, Inc. (CXM) Swings to Q4 Loss

Cardium Therapeutics, Inc. (AMEX: CXM) reported Q4 EPS of ($0.02), versus $0.01 reported last year.

For earnings history and earnings-related data on Cardium Therapeutics, Inc. (CXM) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
• Goldman "broadly" raises estimates for LTL and truckload stocks